Common side effects include nausea and gastrointestinal symptoms, which may influence preferred injection timing during the initial titration phase
Ricinus Communis (Castor) Seed Oil, Octocrylene, Ethylhexyl Methoxycinnamate, Hydrogenated Soy Polyglycerides (and) C15-23 Alkanes, Sorbitan Olivate, Hydrogenated Polyisobutene, Butyrospermum Parkii (Shea) Butter, Color, Ascorbyl Palmitate, Tocopheryl Acetate, Theobroma Cacao (Cocoa) Seed Butter, Persea Gratissima (Avocado) Oil, Caprylic/Capric Triglyceride (and) Polyurethane-79, Flavour, Pentaerythrityl Tetra-Di-T-Butyl Hydroxyhydrocinnamate, Sucralose
Clinical Results and Benefits In the ACHIEVE-3 trial, Orforglipron demonstrated strong results in patients with type 2 diabetes: Hemoglobin A1C reduction of approximately 2.2% Average weight loss of 9.2% (around 20 pounds) Superior outcomes compared to oral semaglutide Additional studies also showed improvements in cardiovascular risk factors, including reductions in LDL cholesterol, triglycerides, and inflammatory markers like C-reactive protein
07(02): e126-e136 PatentUS12233112
When you need to inject into your abdomen, find a spot between your ribs and hips
Sermorelin is the softest nudge to the pituitary